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The present study e.~amined the elTcct of [s-~S]GTP on the funct[ot~ of insulin receptors partially purified from adult rat eardiomyoeytes by WGA 
chromatography, [~'~S]GTP increased receptor autophosphorylation about two times and fully mimicked the stimulatory action of insulha on 
poly(Glu:Tyr) phosphorylatlon with no additional effect of the hormone. The effect of ["~S]GTP was specific, dose.dependent, and due to an increase 
in the Vm,,~ of the kinase. In the presence of ATP or AMP-PNP, insulin significantly enhanced the binding of [~SS]GTP to the partially purified 
insulin receptor. The findings uggest coupling of the insuli,a receptor to a G-protein which may be involved in the regulation of tyrosine klnase 
activity, 
Isolated cardiac myocyte; lnstdin receptor; Guanosine nucleotide binding protein; Tyrosine kinase 
1. INTRODUCTION 
In the past few years evidence has accumulated which 
suggests that insulin receptor signalling may involve 
coupling to GTP-binding proteins [1-7]. This view is 
mainly supported by the effects of cholera and pertussis 
toxin on insulin action. Thus, cholera toxin was found 
to modify insulin signalling in the liver [1] and in the 
heart [7], whereas pertussis toxin attenuates the activa- 
tion of hexose transport and the generation of inosi- 
tolglycan mediators in BC3H-I myocytes [3], and the 
antilipolytic activity of insulin in adipocytes [2]. More 
recently it was found that insulin increases GTP-bind- 
ing to plasma membranes from fat and muscle cells [8,9] 
and that this binding occurs at a 40/41 kDa membrane 
protein very similar or identical to G~ [9,10]. However, 
an effector system which couples to this G-protein spe- 
cies has not been identified until now. 
Recently, Srivastava nd Singh [11] reported the co- 
purification of a GTP-binding protein with the insulin 
recptor, supporting the notion [12013] that the insulin 
receptor is associated with G-proteins which regulate 
receptor fl.nctions. However, controversial findings 
have been reported concerning this hypothesis. Thus, 
Davis and McDonald [13] showed that the tyrosine ki- 
nase activity of the partially purified insulin receptor 
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from adipose tissue is inhibited by [3SSIGTP; however, 
this finding has not been reproduced by Kellerer et al. 
[9] using the same tissue. Furthermore, pertussis toxin 
had no effect on the autophosphorylation and tyrosine 
kinase activity of the insulin receptor in BC~H-I my- 
ocytes [8], whereas [3~S]GTP decreased insulin-mediated 
phosphorylation f endogenous proteins in L 6 muscle 
cells [14]. Interestingly, no activation of insulin receptor 
kinase by [a'~S]GTP has been reported so far, although 
[3~S]GTP can indttce tyrosine phosphorylation in other 
systems [151. 
In the light of our recent observations of G-proteln- 
mediated insulin signalling in isolated ventricular cardi- 
omyocytes [7] we have now investigated the effects of 
[3SS]GTP on the functional activity of insulin receptors 
solubilized fi'om these cells. The data suggest hat car- 
diac insulin receptors are coupled to a G-protein which 
may act as a regulator of tyrosine kinase activity. 
2. MATERIALS AND METHODS 
2.1. Chem&'afs 
[7.--~-'P]ATP (6,000 Ci/mmol) and [~~S]GTP (1.200 Ci/mmoi) were 
purchased fi'om New England Nuclear (Germany}. Reagents far SDS- 
PAGE were supplied by Pharmaeia nd Sigma (Germany), Triton 
K-100, poly(Glu:Tyr)4:1, DTT, [~SS]GTP, [3~S]GDP, WGA coupled 
to agarose, phenylmethylsullbnyl fluoride and aprotinin were from 
Sigma (Germany). Bacitracin, leucine, b~:nzaraidinc, leapeptin and 
pepstatin were obtained fi'om Fluke (Switzerland), Pig moaocompo- 
neat insulin was from Novo (Denmark), All other chemicals were of 
the highest grade commercially available. 
2.2..~;rdubil/'at/on of itta'ttlD1 receptora attd partial purification 
Male Wistar rats fed ad libiturn and wei/~hing 280-320 g were used 
in all experiments, Ca:'*-tolerant myoeytes were isolated by perfusion 
of the laeart with eollagenase azpreviously described by us [ I6], Soitt- 
bilization and purification of insulin receptors from these cells was 
performed according to H':trin8 et al, [17] with modifications, 0,7-1 × 
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107 cells were used for each receptor preparation. Cell lysis was 
achieved by freezing and thawing (three times) the cells in a phosphate 
buffer (composition NaHzPO4 10 mM, sucrose 250 raM, EDTA 5 
raM, glycerol 10%, pH 7.5) containing th~ protease inhibitors ben- 
zamidin (10 mMI, phenylmethylsulfonyl fluoride (5 mM)+ leupeplin 
(2 pM), pepstatin (2 pM) ,  aprotinin (1.2 trypsin inhibiting U/ml). 
bacitracin (0.01%), and leucine (10 mM). The cell lysate was then 
centrifuged for 50 rain at 20,000 xg  and the pelter was solubi|ized for 
90 rain in HEPES buffer (composition HEPES 25 raM, Triton X-100 
I%, phenylmelhylsulfonyl fluoride 2 raM, leupeptin 2 pM,  pepstatin 
2 pM, aprotinin 0.6 trypsin inhibiting U/ml, pH 7,5). Elution buffer 
(composition HEPES 25 raM, NaCI 120 mM, KCI 5 raM, CaCI, 1 
mM, MgSO4 0.8 raM, glycerol 10%) was added to a volume of 10 ml, 
and this material was centrifuged for 90 rain at 100,000 × g. The 
supernatam was diluted 5 times with elution buffer and applied to a 
column of WGA coupled to agar0se. After washing the column with 
50 ml of elution buffer, the bound material was eluted with elution 
buffer containing 0.3 M N-aeetylglucosamine. The fraction containing 
insulin binding activity was frozen in liquid nitrogen and stored at 
-80°C. Protein was determined using a modification of  the Bio-Rad 
protein assay with BSA as a standard. 15-20/Jg glycoprotein was 
obtained from I0" cardiac cells. 
2.3. Autophosphorylation q[ the partially purified irrsulin rec'c'ptor 
3 5 p'g of the WGA-purified insulin receptor was incubated for 30 
rain at 25°C in the absence or presence of the indicated additions in 
a final volume of 30 pt in phosphorylation buffer (HEPES 25 raM. 
MgCI, 10 raM, MnCI, 5 raM, Na~VO+ 0.3 raM, pH 7.5). The reaction 
was initiated by adding 10 pCi of [y-~:P]ATP (linal concentration 28 
pM) and conducted for 10 rain. The incubation was terminated by 
addition of 10 pl of Laemmli [18] sample buffer (250 mM Tris, 8% 
SDS, 20% glycerol, and 0.04% Bromphenol blue), containing tmM 
ATP and 200 mM DTT. and boiling for 10 min. Phosphoproteins were 
analyzed by SDS-PAGE using 4% stacking and 7% resolving els. The 
gels were subjected to autoradiography using Kodak X-Omat AR film 
and intensifying screens. Autoradiographs were quantified by laser- 
s~anning densitometry. Significance ofreported ifferences was evalu- 
ated by using the null hypothesis and t statistics for paired data. 
2.4. A.~.~ay of o'roshze klnase activi O" 
Aliquots (0.6-1 /ug) of the partially purified insulin receptor were 
preincubated in phosphorylation buffer (final vc  ~n~e 65 pl) for 30 min 
at 25°C in the absence or presence of the indicated additions. Incuba- 
tion was then continued for 30 rain in the absence or presence of 
insulin (3.2 × 10 7 M). The phosphorylation reaction was started by 
addition of [yJ-~P]ATP (6/~Ci, final concentration 50/.tM) and the 
exogenous substrate poly(Glu:Tyr) 10.2 m~ml). The reaction was al- 
lowed to proceed for 20 rain and was terminated by addition of 50 mM 
unlabelled ATP and applying triplicate aliquots (10/JI) onto Whatman 
PSI filter papers. The filter papers were extensively washed in 10% 
trichloroacetic a id containing 10 mM sodium pyrophosphate, dried, 
and radioactivity counted by liquid scintillation. Non-specifically 
bound radioactivity was defined as that bound to the filters in the 
absence of poly(Glu:Tyr) and was subtracted from thal bound in the 
presettce of poly(GhuTyr}. 
2.5. [+~S]GTP hhuting assay 
Binding of ['sSIGTP to WGA-purified proteins was determined by 
incubating 0.5-1/zg glyeoprotein i  phosphorylation buffer at 25°C 
in a final volume of 100/Jl. After preincubating the protein solution 
for 30 rain in the absence or presence of insulin, the binding reaction 
was initiated by the addition of I /zCi [~~SIGTP (final concentration 
10 nM) and terminated at the indicated times by the addition of 2 ml 
of ice-cold stop solution (Tris 20 mM, NaCI 10fl raM. MgCI: 25 mM. 
pH 8.0) followed by rapid filtration through B85 nitrocellulose filters 
{Schleicher & Schuelll. The filters were washed with 7 ml slop ~olution. 
dried and placed into I0 ml of scintillation fluid. Radioactivity was 
then determined in a Beckman LS 6000 IC scintillation counter. All 
experiments were performed in triplicate, Non-specific binding wa~ 
determined in parallel incubations in the presence of 100 pM unla- 
belied GTP. All binding data reported represent specific binding de- 
fined as the difference between total and non-specific binding. 
3. RESULTS 
Preincubation of the partially purified insulin recep- 
tor with ['~sS]GTP resulted in an increased incorporation 
of ~'-P into the 95 kDa ~-subunit o f  the insulin receptor 
(Fig. 1). As presented in Table I, the nudeotide in- 
creases autophosphorylation about two times, reaching 
about one half of the stimulatory action of insulin ob- 
tained at maximal concentrations of  the hormone. It 
may be argued that the effect of  [~SS]GTP is related to 
elevated ATP concentrations during the incubation pe- 
riod due to an inhibition of nucleotidase activity. How- 
ever+ under all incubation conditions no significant al- 
teration of  the total ATP concentration (50 pM) could 
be detected using the firefly luciferase assay [7]. 
In order to elucidate if the [-~sS]GTPoindueed increase 
in autophosphorylation of the insulin receptor leads to 
an increased tyrosine kinase activity, we have studied 
kDa 
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Fig. l ,  E f fec t  o f  I-~S]GTP on insul in receptor  autophosphory ia t ion ,  
3-5 pg of partially purified insulin receptor were preincubated for 30 
min in the absence or presence of [aSS]GTP (200/tiM). Incubation was 
then continued for an additional 30 rain in the absence or presence of 
insulin (3.5 × 10 -~ M}. The phosphorylation reaction was initiated by 
adding 28/JM [~-'P]ATP and conducted for 10 rain. Phosphoproteins 
were separated by SDS-PAGE and subjected to autoradiography. A 
representative autoradiogram of three separate xperiments is shown. 
Table l 
Effect of insulin and [;~S]GTP on insulin receptor ]l-subunit auto- 
phosphorylation 
Incubation conditions fl-subunit autophosphorylation 
(% of maximum) 
Basal 21.5 _+ 3.9 
Insulin 88.7 +_ II.2 
["SIGTP 38.7 +_ 8.9* 
Insulin + I'SS]GTP 97.5 _+ 2.5 
Experimental conditions are described in the legend to Fig. I. The 
relative amount of/~-subunit autophosphorylation was determined by 
laser-scanning densitometry of individual autoradiograms. Mean val- 
ues (~ of maximum~ of three separate xperiments (_+S.E.M.) are 
shown. 
*Significantly different from basal wilh P < 0.05. 
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the effect of the nucleotide on insulin stimulated phos- 
phorylation of  the synthetic substrate poly(Glu:Tyr). 
reflecting the intrinsic tyrosine kinase activity of the 
receptor. As presented in Fig. 2, preiiicubation with 
[~SS]GTP ( I00/ /M) fully mimicked the stimulatory ac- 
t=on of insulin on poly(Glu:Tyr) phosphorylation. 
Under these conditions no significant effect of the 
hormone on poly(Glu:Tyr) phosphorylation could be 
detected, suggesting that [3sS]GTP stimulates the insulin 
receptor kinase in an insulin-like fashion. In contrast, 
the pyrimidin¢ triphosphate, CTP, did not influence 
basal and insulin stimulated poly(Glu:Tyr) phosphoryl- 
ation. 
The effect of ['~sS]GTP was dose-dependent, with a 
maximal effect ofthe nucleotide at 100pM (Fig. 3). The 
stimulatory action of [~SS]GTP persisted even up to 1 
mM. ['~SS]GDP, an antagonist of G-protein-mediated 
functions, was without effect on poly(Glu:Tyr) phos- 
phorylation. To further characterize the mechanism of 
GTP action, the ATP concentration was varied in the 
range of 12.5 MM up to 200 pM.  Lineweaver-Burk 
analysis of the phosphorylation of the synthetic pol- 
ypeptidc in the absence or presence of  [~sS]GTP (100 
#M) showed that the Km of the partially purified insulin 
receptor for poly(Glu:Tyr) phosphorylation was not 
significantly affected by [3~S]GTP (43 and 54.1 pM for 
control and [35SlGTP, respectively). However, the I:,,,~ 
increased from 1.88 to 3.46 pmol//tg protein x 20 min 
when preincubating the receptor with [3SS]GTP. This 
agrees with the well-established ffect of  insulin on insu- 
lin receptor tyrosine kinase activity, which is exclusively 
due to an increase in V=~ [19]. 
The effects of [-~-~S]GTP on the function of solubilized 
insulin receptors may involve either a direct interaction 
1.5 
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Fig. 2. Effect o f  [3SS]GTP and CTP on exogenous ubs(rate protein 
kinase activity o f  the WGA-agarose-purif ied insulin receptor. Aliq- 
uots (0.f~l/tg} o f  the glycoprotein fraction were preincubated for 30 
rain in the absence (control} or presence of  [~S]GTP | [00/JM) or CTP 
(100 pM).  Incubation was then continued for 30 rain in the absence 
or presence of  insulin {3.2 × 10 : M}, Poly(Glu:Tyr) (0.2 mg/ml) phos- 
phorylation was then determined using 50 aM ATP as described in 
section 2. Data are means + S.E.M. obtained from three independent 
receptor preparations. 
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Fig. 3. Effect of [~S]GTP concentration on exogenous subs(rate pro- 
tein kinase activity. Partially purifi~xl insttlin rt'ceptor was prcincu- 
bated with the indicated concentrations o f guanosine nuclcotides for 
30 rain. Kinase activity was then determined as outlined in Fig. 2. 
Values are means + S.E.M. (n = 3-4l. *Significantly different from 
control with P < 0.05. 
of the receptor with the nucleotide or a GTP-binding 
protein closely coupled to the receptor. Since hormone 
receptors which couple to G-proteins increase the bind- 
ing of GTP, we have studied the effect of insulin on the 
time-course of [35S]GTP binding to WGA-purified pro- 
teins. As shown in Fig. 4 {upper panel), insulin signifi- 
cantly enhanced [-~S]GTP binding with a most promi- 
nent effect (196% of control) at early time points. When 
ATP was removed from the incubation medium (Fig. 4, 
middle panel), the effect of insulin was no longer detect- 
able. In order to elucidate if autophosphorylation of the 
insulin receptor ~-subunit may be essential for coupling 
to the G-protein system, a similar experiment was per- 
formed, substituting ATP by the non-hydrolyzable ana- 
logue, AMP-PNP. As presented in Fig. 4 {lower panel}, 
the effect of ATP can be fully mimicked by AMP PNP, 
suggesting that the insulin receptor interacts with the 
G-protein in a tyrosine kinase-independent fashion. 
4. DISCUSSION 
Originally it was thought hat coupling to GTP-bind- 
ing proteins is exclusively limited to hormone receptors 
with several membrane spanning domains [20]. How- 
ever, more recent studies suggest hat single-spanning 
receptors, like epidermal growth factor receptor [21], 
insulin-like growth factor-I [22] and -II [23] receptor. 
and insulin receptor, may also be cnupled to G-proteins. 
In the latter case, the situation may be even more com- 
plex. Thus, GTP-binding proteins have been suggested 
to be involved in insulin signalling both at the receptor 
[9,13,24] and the post-receptor level [7,14,25]. The iden- 
tity of the G-proteins and the functional implications, 
however, remain poorly understood. 
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Fig. 4. Effect of  insulin on [ 'S IGTP  binding to WGA-purif ied pro- 
teins. Glycoprotein (0.5-1/~g) was incubated for 30 rain at 25°C in the 
absence (~) or presence ( i)  of  insulin ( I /aM).  1 /aCi [~SS]GTP (final 
concentration 10 nM) was then added and binding was measured as
detailed in section 2. All data have been corrected for non-specific 
binding, lopper panel) All incubations were performed in the presence 
of ATP 50/aM). (Middle panel) No adenosine ucleotide present. 
(Lower pan|l) All incubations were performed in the presence of 
AMP- PNP {500/aM). Values are means +_ S.E.M. of 34 receptor 
preparations. *Not significantly different from control with P > 0.05. 
In the present investigation we have used insulin re- 
ceptors olubilized from ventricular cardiomyocytes in 
order to test the hypothesis that the insulin receptor is 
closely coupled to a G-protein, which may operate as 
a regulator of insulin receptor functions. A major find- 
ing is the observation that [3SS]GTP increases auto- 
phosphorylation, and most probably thereby activates 
the tyrosine kinase activity of  the receptor preparation. 
Several ines of  evidence suggest hat the nucleotide 
mimicks the effect of insulin on the tyrosine kinaseac- 
tivity of  the isolated insulin receptor. First, [3SS]GTP 
increased poly(Glu:Tyr) phosphorylation to the level 
observed with insulin; second, no additive ffect of the 
hormone could be detected; and third, [35S]GTP in- 
creased the Vmax of the kinase in agreement with the 
effect of  insulin [19]. 
In contrast o our findings, Davis and McDonald 
[13], using adipocyte insulin receptors, recently reported 
on an inhibition offl-subunit autophosphorylation and 
a reduction of  tyrosine kinase activity by [3SS]GTP at 
high concentrations of the nucleotide. Furthermore, 
Kelleret et al. [9] described an inhibition of insulin- 
stimulated receptor kinase activity by [3~S]GTP in adi- 
pocyte plasma membrane preparations. The apparent 
discrepancy between these studies and our results may 
be explained by very recent observations from Mc- 
Donald's group, published in abstract form [26], in 
which it was shown that placenta insulin receptors are 
associated with a 67 and a 41 kDa G-protein. Removal 
of the 67 kDa G-protein increases the tyrosine kinase 
activity, whereas the 41 kDa G-protein is suggested to 
be responsible for insulin sensitivity of the kinase. Since 
the purification protocol may affect he amount and the 
nature of  G-proteins associated with the insulin recep- 
tor, differing results concerning kinase regulation are 
not surprising. Preliminary photolabeling experiments 
in our laboratory have shown that the purified insulin 
receptor preparation indeed contains a variety of G- 
proteins, but only one species is activated by insulin. In 
light of the above mentioned observations [26] our data 
would be compatible with the dissociation of a G-pro- 
tein from the receptor upon addition of [3sS]GTP, fi- 
nally leading to a kinase activation. 
The assumption that [35S]GTP binds to a G-protein 
and not to the insulin receptor itself is supported by 
earlier work showing that GTP has no effect on highly 
purified insulin receptor preparations [27]. Additional 
evidence for the functional relationship between the 
WGA-purified insulin receptor and a G-protein is ob- 
tained from the studies on [3-~S]GTP binding. Insulin 
increased [3SS]GTP binding under conditions which are 
required for insulin signalling, suggesting that the insu- 
lin receptor is closely coupled, most probably associated 
with a G-protein. Consistently, the co-purification of 
G-proteins with the insulin receptor has been reported 
by several groups [1 i,26]. 
Insulin receptor/G-protein coupling was observed in 
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the presence o f  ATP  or  AMP-PNP,  but  cou ld  not  be 
detected in the absence  o f  these nuc leot ides.  This  find- 
ing suggests that  the communicat ion  between the insulin 
receptor  and  the G-prote in  system does  not  involve au- 
tophosphory la t ion  o f  the insulin receptor .  However ,  in- 
sulin s ignal l ing appears  to be dependent  on  the presence 
o f  ATP ,  most  p robab ly  on  the b ind ing  o f  the  nuc leot ide 
to the f l - subun i t  o f  the  insulin receptor ,  The  lat ter  find- 
ing agrees well  w i th  a recent repor t  by  Maddux and 
Go ld f ine  [28] showing  that  insul in p lus ATP  may induce 
a conformat iona l  change in the f l - subun i t  w i thout  in- 
ducing receptor  autophosphory la t ion .  In l ight  o f  our  
f indings it may be speeulated that  conformat iona l  
changes o f  the insu l in  receptor  esult in a non-cova lent  
interact ion wi th  G-prote ins .  Fur thermore ,  in this model  
o f  non-cova lent  insul in  receptor /G-prote in  coupl ing,  a 
G-prote in -med ia ted  act ivat ion o f  the insul in  receptor  
tyros ine k inase  by  insul in would  represent  a putat ive 
pathway o f  insul in  s ignal l ing in target  cells. Th is  hy- 
pothesis,  a l though stil l  h ighly speculat ive,  needs further 
attent ion.  
Taken  together ,  the present study suppor ts  the not ion 
that the insul in receptor  interacts with a G-prote in  and 
that this in teract ion  modu la tes  receptor  funct ions.  
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